These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18674539)

  • 1. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44).
    Edes IF; Tóth A; Csányi G; Lomnicka M; Chłopicki S; Edes I; Papp Z
    J Mol Cell Cardiol; 2008 Sep; 45(3):363-72. PubMed ID: 18674539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
    Drelicharz L; Kozlovski V; Skorka T; Heinze-Paluchowska S; Jasinski A; Gebska A; Guzik T; Olszanecki R; Wojnar L; Mende U; Csanyi G; Chlopicki S
    Basic Res Cardiol; 2008 Sep; 103(5):417-30. PubMed ID: 18431525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium.
    van der Velden J; Narolska NA; Lamberts RR; Boontje NM; Borbély A; Zaremba R; Bronzwaer JG; Papp Z; Jaquet K; Paulus WJ; Stienen GJ
    Cardiovasc Res; 2006 Mar; 69(4):876-87. PubMed ID: 16376870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.
    Goldspink PH; Montgomery DE; Walker LA; Urboniene D; McKinney RD; Geenen DL; Solaro RJ; Buttrick PM
    Circ Res; 2004 Aug; 95(4):424-32. PubMed ID: 15242976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of magnetic resonance imaging in vivo for the assessment of the progression of systolic and diastolic dysfunction in a mouse model of dilated cardiomyopathy.
    Drelicharz Ł; Woźniak M; Skórka T; Tyrankiewicz U; Heinze-Paluchowska S; Jabłońska M; Gebska A; Chłopicki S
    Kardiol Pol; 2009 Apr; 67(4):386-95. PubMed ID: 19492251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserved cardiomyocyte function and altered desmin pattern in transgenic mouse model of dilated cardiomyopathy.
    Mackiewicz U; Czarnowska E; Brudek M; Pająk B; Duda M; Emanuel K; Csanyi G; Fedorowicz A; Grochal E; Tyrankiewicz U; Skórka T; Mende U; Lewartowski B; Chłopicki S
    J Mol Cell Cardiol; 2012 May; 52(5):978-87. PubMed ID: 22285482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype.
    Mende U; Semsarian C; Martins DC; Kagen A; Duffy C; Schoen FJ; Neer EJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1477-91. PubMed ID: 11448136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed Frank-Starling mechanism in the left ventricular muscle of the knock-in mouse model of dilated cardiomyopathy with troponin T deletion mutation ΔK210.
    Inoue T; Kobirumaki-Shimozawa F; Kagemoto T; Fujii T; Terui T; Kusakari Y; Hongo K; Morimoto S; Ohtsuki I; Hashimoto K; Fukuda N
    J Mol Cell Cardiol; 2013 Oct; 63():69-78. PubMed ID: 23863340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
    Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
    Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy.
    Elas M; Bielanska J; Pustelny K; Plonka PM; Drelicharz L; Skorka T; Tyrankiewicz U; Wozniak M; Heinze-Paluchowska S; Walski M; Wojnar L; Fortin D; Ventura-Clapier R; Chlopicki S
    Free Radic Biol Med; 2008 Aug; 45(3):321-8. PubMed ID: 18466775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation.
    Du CK; Morimoto S; Nishii K; Minakami R; Ohta M; Tadano N; Lu QW; Wang YY; Zhan DY; Mochizuki M; Kita S; Miwa Y; Takahashi-Yanaga F; Iwamoto T; Ohtsuki I; Sasaguri T
    Circ Res; 2007 Jul; 101(2):185-94. PubMed ID: 17556660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic atrial fibrillation on active and passive force generation in human atrial myofibrils.
    Belus A; Piroddi N; Ferrantini C; Tesi C; Cazorla O; Toniolo L; Drost M; Mearini G; Carrier L; Rossi A; Mugelli A; Cerbai E; van der Velden J; Poggesi C
    Circ Res; 2010 Jul; 107(1):144-52. PubMed ID: 20466979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine, and porcine cardiomyocytes.
    Edes IF; Czuriga D; Csányi G; Chlopicki S; Recchia FA; Borbély A; Galajda Z; Edes I; van der Velden J; Stienen GJ; Papp Z
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R20-9. PubMed ID: 17110532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation.
    Scruggs SB; Walker LA; Lyu T; Geenen DL; Solaro RJ; Buttrick PM; Goldspink PH
    J Mol Cell Cardiol; 2006 Apr; 40(4):465-73. PubMed ID: 16445938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated cardiomyopathy mutation (R174W) in troponin T attenuates the length-mediated increase in cross-bridge recruitment and myofilament Ca
    Reda SM; Chandra M
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H648-H657. PubMed ID: 31373515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts.
    Balogh A; Santer D; Pásztor ET; Tóth A; Czuriga D; Podesser BK; Trescher K; Jaquet K; Erdodi F; Edes I; Papp Z
    Cardiovasc Res; 2014 Jan; 101(1):108-19. PubMed ID: 24127233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
    Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
    Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells.
    Borbély A; Tóth A; Edes I; Virág L; Papp JG; Varró A; Paulus WJ; van der Velden J; Stienen GJ; Papp Z
    Cardiovasc Res; 2005 Aug; 67(2):225-33. PubMed ID: 16005301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.